Alert
Coverage for Insulin, Epinephrine, and Asthma Inhalers
A new law, P.L. 2023, c. 105, enhances benefits for insulin, epinephrine, and inhalers by
requiring coverage for the purchase of these medications, eliminating deductibles for these
expenses, and capping copayments or coinsurance payments. For patients with benefit plans
covered by P.L. 2023, c. 105—including, but not limited to, health insurance plans that provide
hospital or medical expense benefits, with certain limited exceptions—the following new
provisions may improve access to insulin, epinephrine, and inhalers:
Read Complete Notice Here Alert Reminder regarding prescriptions from APNsDuring New Jersey’s declared state of emergency resulting from the COVID-19 pandemic, pharmacists may fill prescriptions written by Advanced Practice Nurses (APNs), to include prescriptions that do not include the name of a collaborating physician. Pursuant to Governor Murphy’s
Executive Order 112 and pursuant to the
Division of Consumer Affairs’ Administrative Order 2020-02, statutory and regulatory requirements that would otherwise mandate that an APN maintain a joint protocol with a collaborating physician, and that the collaborating physician’s name, address and telephone number be included on prescriptions written by the APN, have been waived. Although the public health emergency originally declared in Executive Order 112 has ended, the state of emergency remains in effect. Additionally, pursuant to
Executive Order 292, the cited provisions of both EO 112 and AO 2020-02 remain in full force and effect at this time.
